The first “shining star” baby

Israeli doctors delivered by Caesarian section the first baby born at the “Shining Star” Israeli field hospital in Ukraine. Mother and baby are doing well.

Israeli Arab leads Ukraine field hospital lab

Arab-Israeli Amir Zoabi heads up the laboratory at the Israeli field hospital in Ukraine. Set-up in an unused schoolroom, his lab can conduct any required test. In this article Amir shares his feelings about being part of the Israeli humanitarian delegation.

Eye-opening breakthrough

Doctors at Jerusalem’s Shaare Zedek Medical Center have performed the first implant of the thinnest artificial cornea ever printed in the world. The 50-micron thick EndoArt implant (see previously) reduces recovery time and risk of rejection. The patient had a previous human cornea rejected.

US approval for fast diagnosis of collapsed lung

Israel’s Aidoc (see previously) has received US FDA approval for its newly developed X-ray solution that detects cases of pneumothorax (collapsed lung) on X-rays for more efficient triage. Fast diagnosis of the condition can prevent subsequent respiratory or cardiac failures.

Toxic cancer treatment made safe

Scientists at Israel’s Weizmann Institute have improved a cancer therapy that killed tumors but was too toxic for use.  They added a specially created antibody that targets only the CD40 receptor protein molecule which stimulates the immune system to fight the cancer.

Natural antibodies fight cancer too

Scientists at Israel’s Weizmann Institute have discovered that in addition to cancer-fighting T-cells, the immune system’s B-lymphocytes also produce antibodies that take part in battles against cancer cells. They target the enzyme MMP14, a cause of metastasis and can be used in future therapies.

Ukraine field hospital treats thousands

Israel’s “Shining Star” field hospital has been established by the Israel Ministry of Foreign Affairs, the Ministry of Health, and Sheba Medical Centre, assisted by Israel’s healthcare system. In its first week it treated 1,100+ adults and children, including a 10-year-old heart patient.

Second booster reduced deaths by 78%

Israeli HMO Clalit, Sapir College and Ben-Gurion University studied 563,465 Israelis aged 60-100 who were eligible for the fourth coronavirus vaccine. They reported a 78% decrease in COVID deaths. In a 40-day period.

International research grants

Ben Gurion University’s Dr. Shai Pilosof has won a $100,000 grant from the International Human Frontier Science Program Organization (HFSP) for researching animals and environment. His colleague Dr Benjamin Palmer is investigating the diversity of color in the natural world.

Accurate diagnosis

Tel Aviv University researchers have discovered that after a minor head injury many children later displayed symptoms that were often misdiagnosed as ADHD. 200 children were monitored and 25% were found to suffer chronic persistent post-concussion syndrome, requiring much different treatment.